Literature DB >> 10449983

Age-dependent retinoic acid regulation of gene expression distinguishes the cervical, thoracic, lumbar, and sacral spinal cord regions during development.

W W Rubin1, A S LaMantia.   

Abstract

We evaluated whether differences in the availability of retinoic acid (RA) establish distinct patterns of RA-dependent gene expression in the embryonic mouse thoracic/sacral versus cervical/lumbar spinal cord regions. Exogenous RA elicits ectopic expression of an RA-activated transgene and the RA receptor beta in the dorsal thoracic and sacral cord in mice at embryonic day (E) 12.5, but not E14.5. This age-dependent regulation is cell autonomous and is not accompanied by changes in expression patterns of several retinoid receptors, binding proteins, or the SMRT nuclear corepressor. Instead, this change apparently reflects the loss of endogenous RA in the dorsal thoracic and sacral cord between E12.5 and E14.5. Thus, chronic exposure to exogenous RA between E11.5 and E13.5 restores ectopic RA-mediated gene expression. These observations suggest that the local availability of RA establishes absolute differences in gene expression that distinguish the thoracic and sacral cord from the cervical and lumbar cord during midgestation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10449983     DOI: 10.1159/000017373

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  2 in total

1.  Analysis of uracil-DNA glycosylases from the murine Ung gene reveals differential expression in tissues and in embryonic development and a subcellular sorting pattern that differs from the human homologues.

Authors:  H Nilsen; K S Steinsbekk; M Otterlei; G Slupphaug; P A Aas; H E Krokan
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

Review 2.  The strengths of the genetic approach to understanding neural systems development and function: Ray Guillery's synthesis.

Authors:  Anthony-Samuel LaMantia
Journal:  Eur J Neurosci       Date:  2018-08-01       Impact factor: 3.386

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.